Cheng et al. suggested that miR-142 targets PLA2G16 through the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway to inhibit the proliferation of osteosarcoma cells and promote their apoptosis [35]. The gene discussed is MAPK3; the disease is osteosarcoma.